X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10880) 10880
Book Chapter (427) 427
Newsletter (299) 299
Newspaper Article (216) 216
Magazine Article (18) 18
Book / eBook (7) 7
Transcript (5) 5
Publication (4) 4
Reference (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (8901) 8901
humans (8604) 8604
life sciences & biomedicine (8538) 8538
female (3560) 3560
animals (3489) 3489
monoclonal antibodies (3368) 3368
antibodies, monoclonal - therapeutic use (2970) 2970
oncology (2750) 2750
male (2653) 2653
antibodies, monoclonal, humanized (2158) 2158
pharmacology & pharmacy (2072) 2072
middle aged (1967) 1967
adult (1805) 1805
cancer (1724) 1724
treatment outcome (1715) 1715
antibodies, monoclonal, humanized - therapeutic use (1595) 1595
aged (1589) 1589
antibodies (1585) 1585
mice (1488) 1488
care and treatment (1420) 1420
research (1282) 1282
immunology (1275) 1275
antibodies, monoclonal - administration & dosage (1259) 1259
antibodies, monoclonal - pharmacokinetics (1258) 1258
clinical trials (1248) 1248
medicine & public health (1186) 1186
antibodies, monoclonal - adverse effects (1132) 1132
drug therapy (1127) 1127
bevacizumab (1108) 1108
antineoplastic agents - therapeutic use (1079) 1079
antibodies, monoclonal, humanized - administration & dosage (1053) 1053
health aspects (1052) 1052
immunotherapy (1044) 1044
antibodies, monoclonal - pharmacology (1007) 1007
pharmacokinetics (919) 919
proteins (893) 893
analysis (872) 872
medicine, research & experimental (871) 871
research & experimental medicine (871) 871
tumors (865) 865
clinical trials as topic (861) 861
monoclonal antibody (849) 849
trastuzumab (799) 799
immunoglobulins (790) 790
antibodies, monoclonal - immunology (783) 783
antibodies, monoclonal, humanized - adverse effects (781) 781
chemotherapy (771) 771
antibodies, monoclonal, humanized - pharmacokinetics (758) 758
review (726) 726
cell line, tumor (723) 723
antineoplastic combined chemotherapy protocols - therapeutic use (717) 717
hematology (714) 714
dose-response relationship, drug (678) 678
patients (662) 662
medical research (635) 635
pharmacology/toxicology (628) 628
viral antibodies (628) 628
breast cancer (616) 616
biotechnology & applied microbiology (615) 615
neoplasms - drug therapy (573) 573
abridged index medicus (563) 563
aged, 80 and over (563) 563
metastasis (556) 556
antibodies, monoclonal, humanized - pharmacology (554) 554
antigens (551) 551
pharmacology (548) 548
breast neoplasms - drug therapy (542) 542
studies (531) 531
internal medicine (502) 502
drug dosages (484) 484
cancer therapies (479) 479
biological products (476) 476
biochemistry & molecular biology (472) 472
antineoplastic agents - pharmacology (471) 471
angiogenesis inhibitors - therapeutic use (467) 467
cancer research (464) 464
vascular endothelial growth factor (462) 462
medicine (455) 455
cetuximab (453) 453
vascular endothelial growth factor a - antagonists & inhibitors (450) 450
biomedicine (443) 443
tissue distribution (440) 440
ophthalmology (439) 439
adolescent (432) 432
cytotoxicity (432) 432
rheumatoid arthritis (429) 429
cytokines (426) 426
young adult (425) 425
mice, nude (424) 424
antineoplastic agents - administration & dosage (419) 419
dosage and administration (411) 411
pharmacotherapy (410) 410
immunoglobulin g (407) 407
antineoplastic agents (403) 403
antineoplastic agents - adverse effects (399) 399
antineoplastic agents - pharmacokinetics (396) 396
double-blind method (391) 391
antibodies, monoclonal - chemistry (384) 384
research article (384) 384
drug administration schedule (383) 383
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11816) 11816
German (30) 30
Japanese (27) 27
French (18) 18
Chinese (9) 9
Spanish (7) 7
Italian (6) 6
Danish (3) 3
Norwegian (3) 3
Portuguese (3) 3
Polish (2) 2
Russian (2) 2
Arabic (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 09/2015, Volume 10, Issue 9, pp. e0137345 - e0137345
.... We previously found increased expression of CD47 on primary human acute myeloid leukemia (AML) stem cells, and demonstrated that blocking monoclonal antibodies directed... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Phagocytosis - drug effects | Antibodies, Monoclonal, Humanized - therapeutic use | Antineoplastic Agents - immunology | Leukemia, Myeloid, Acute - pathology | Humans | Antibodies, Monoclonal - pharmacokinetics | Macaca fascicularis | Antibodies, Monoclonal - therapeutic use | Antibody Affinity | Antineoplastic Agents - therapeutic use | Leukemia, Myeloid, Acute - immunology | CD47 Antigen - immunology | Haplorhini | Rituximab - therapeutic use | Animals | Antibodies, Monoclonal, Humanized - pharmacokinetics | Leukemia, Myeloid, Acute - drug therapy | Female | Antineoplastic Agents - pharmacokinetics | Mice | Mice, Inbred BALB C | Tumor Cells, Cultured | Antibodies, Monoclonal, Humanized - immunology | Antibodies, Monoclonal - immunology | Monoclonal antibodies | Physiological aspects | Genetic aspects | Research | Non-Hodgkin's lymphomas | Drug therapy | Animal models | Leukemia | Immunoglobulin G | Xenotransplantation | Clinical trials | Stem cell transplantation | Biology | Macrophages | Cancer therapies | Cell surface | Proteins | Signal transduction | Allografts | Xenografts | Primates | Chemical bonds | Bone marrow | Chief executive officers | Drug dosages | Immune system | Medical research | Complementarity | Dendritic cells | Myeloid leukemia | Rituximab | Lymphoma | Medicine | Serum levels | Chemotherapy | Medical prognosis | Stem cells | Solid tumors | Acute myeloid leukemia | Phagocytosis | Cancer | Apoptosis | Tumors | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article
Molecular cancer therapeutics, ISSN 1538-8514, 05/2012, Volume 11, Issue 5, pp. 1133 - 1142
.... In previous animal studies, T-DM1 exhibited better pharmacokinetics (PK) and slightly more efficacy than several disulfide-linked versions... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Cell Survival - drug effects | Maytansine - analogs & derivatives | Humans | Receptor, ErbB-2 - metabolism |